First-in-class multifunctional TYMS nonclassical antifolate inhibitor with potent in vivo activity that prolongs survival

Author:

Guijarro Maria V.ORCID,Kellish Patrick C.ORCID,Dib Peter E.ORCID,Paciaroni Nicholas G.ORCID,Nawab Akbar,Andring JacobORCID,Kulemina Lidia,Borrero Nicholas V.,Modenutti CarlosORCID,Feely Michael,Nasri ElhamORCID,Seifert Robert P.ORCID,Luo XiaopingORCID,Bennett Richard L.ORCID,Shabashvili Daniil,Licht Jonathan D.ORCID,McKenna RobertORCID,Roitberg Adrian,Huigens Robert W.ORCID,Kaye Frederic J.,Zajac-Kaye MariaORCID

Funder

National Cancer Institute

University of Florida

Florida Department of Health

Publisher

American Society for Clinical Investigation

Subject

General Medicine

Reference52 articles.

1. Standing the test of time: targeting thymidylate biosynthesis in cancer therapy

2. Characterization of a thymidylate synthase (TS)-inducible cell line: a model system for studying sensitivity to TS- and non-TS-targeted chemotherapies;Longley;Clin Cancer Res,2001

3. Thymidylate synthase gene and protein expression correlate and are associated with response to 5-fluorouracil in human colorectal and gastric tumors;Johnston;Cancer Res,1995

4. p53 and thymidylate synthase expression in untreated stage II colon cancer: associations with recurrence, survival, and site;Lenz;Clin Cancer Res,1998

5. Colorectal tumors responding to 5-fluorouracil have low gene expression levels of dihydropyrimidine dehydrogenase, thymidylate synthase, and thymidine phosphorylase;Salonga;Clin Cancer Res,2000

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3